BAYER AG
π©πͺGermany
- Country
- π©πͺGermany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon
Completed
- Conditions
- Multiple Sclerosis
- Interventions
- Drug: Interferon beta-1b (Betaferon, BAY 86-5046)
- First Posted Date
- 2013-01-11
- Last Posted Date
- 2018-02-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 138
- Registration Number
- NCT01766063
Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
Phase 3
Completed
- Conditions
- Bronchiectasis
- Interventions
- Drug: PlaceboDrug: Ciprofloxacin DPI (BAYQ3939)
- First Posted Date
- 2013-01-10
- Last Posted Date
- 2018-01-24
- Lead Sponsor
- Bayer
- Target Recruit Count
- 416
- Registration Number
- NCT01764841
BAY86-9766 Plus Gemcitabine Phase I Study in Asian
- First Posted Date
- 2013-01-10
- Last Posted Date
- 2018-11-01
- Lead Sponsor
- Bayer
- Target Recruit Count
- 23
- Registration Number
- NCT01764828
EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan
Completed
- Conditions
- Macular Degeneration
- Interventions
- First Posted Date
- 2012-12-25
- Last Posted Date
- 2018-06-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 757
- Registration Number
- NCT01756261
EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan
Completed
- Conditions
- Macular Degeneration
- Interventions
- Drug: Aflibercept(Eylea, VEGF Trap-Eye, BAY86-5321)
- First Posted Date
- 2012-12-25
- Last Posted Date
- 2023-06-07
- Lead Sponsor
- Bayer
- Target Recruit Count
- 3872
- Registration Number
- NCT01756248
Sorafenib for Residue Disease After Resection With Curative Intent
- First Posted Date
- 2012-12-18
- Last Posted Date
- 2017-09-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 106
- Registration Number
- NCT01751763
Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia
- First Posted Date
- 2012-12-17
- Last Posted Date
- 2017-09-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 2297
- Registration Number
- NCT01750788
A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
Completed
- Conditions
- ContraceptionMenorrhagia
- Interventions
- Device: ESS305 (Essure, BAY1454032)Procedure: NovaSure
- First Posted Date
- 2012-12-04
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- Bayer
- Target Recruit Count
- 211
- Registration Number
- NCT01740687
DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users.
- First Posted Date
- 2012-11-21
- Last Posted Date
- 2015-07-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 207
- Registration Number
- NCT01731132
Sorafenib in Elderly mRCC
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2017-11-09
- Lead Sponsor
- Bayer
- Target Recruit Count
- 60
- Registration Number
- NCT01728948
Β© Copyright 2025. All Rights Reserved by MedPath